Skip to main content

Navigation group

Type at least 3 characters

20 articles

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Articles

Original Research

Published on 07 Apr 2022

Highly Efficient Autologous HIV-1 Isolation by Coculturing Macrophage With Enriched CD4+ T Cells From HIV-1 Patients

in Antivirals and Vaccines

Cristina Xufré
Tanía González
Lorna Leal
Charles M. Trubey
Jeffrey D. Lifson
José María Gatell
José Alcamí
Núria Climent
Felipe García
Sonsoles Sánchez-Palomino

Highly Efficient Autologous HIV-1 Isolation by Coculturing Macrophage With Enriched CD4+ T Cells From HIV-1 Patients

Frontiers in Virology

doi 10.3389/fviro.2022.869431

2,339 views

Brief Research Report

Published on 15 Dec 2021

Iota-Carrageenan Prevents the Replication of SARS-CoV-2 in a Human Respiratory Epithelium Cell Line in vitro

in Antivirals and Vaccines

Augusto Varese
Ana Paletta
Ana Ceballos
Carlos Adolfo Palacios
Juan Manuel Figueroa
Andrea Vanesa Dugour

Iota-Carrageenan Prevents the Replication of SARS-CoV-2 in a Human Respiratory Epithelium Cell Line in vitro

Frontiers in Virology

doi 10.3389/fviro.2021.746824

23,705 views
10 citations

Review

Published on 23 Aug 2021

Defining Efficacy of Chikungunya Virus Candidate Vaccines: Different Endpoints Derived From the Virus—Cytokine—Ferritin (VCF) Model

in Antivirals and Vaccines

Stephanie M. Lim
Sudip K. Dutta
Byron E. E. Martina

Defining Efficacy of Chikungunya Virus Candidate Vaccines: Different Endpoints Derived From the Virus—Cytokine—Ferritin (VCF) Model

Frontiers in Virology

doi 10.3389/fviro.2021.693439

4,293 views
1 citation

Specialty Grand Challenge

Published on 24 May 2021

Vaccines and Antivirals: Grand Challenges and Great Opportunities

in Antivirals and Vaccines

Graciela Andrei

Vaccines and Antivirals: Grand Challenges and Great Opportunities

Frontiers in Virology

doi 10.3389/fviro.2021.666548

11,062 views
24 citations